Form 4 holding
President and CEO, Director
BELLICUM PHARMACEUTICALS, INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 400,000
- Estimated value
- Report date
- 15 Aug 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount